These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 32238701)
1. Lipid Nanoparticles for Cell-Specific in Vivo Targeted Delivery of Nucleic Acids. Khalil IA; Younis MA; Kimura S; Harashima H Biol Pharm Bull; 2020; 43(4):584-595. PubMed ID: 32238701 [TBL] [Abstract][Full Text] [Related]
2. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy. Francia V; Schiffelers RM; Cullis PR; Witzigmann D Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370 [TBL] [Abstract][Full Text] [Related]
3. How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances. Rehman Zu; Zuhorn IS; Hoekstra D J Control Release; 2013 Feb; 166(1):46-56. PubMed ID: 23266451 [TBL] [Abstract][Full Text] [Related]
4. Lipid-nucleic acid nanoparticles of novel ionizable lipids for systemic BMP-9 gene delivery to bone-marrow mesenchymal stem cells for osteoinduction. Vhora I; Lalani R; Bhatt P; Patil S; Misra A Int J Pharm; 2019 May; 563():324-336. PubMed ID: 30954673 [TBL] [Abstract][Full Text] [Related]
5. Lipid nanoparticles for nucleic acid delivery: Current perspectives. Samaridou E; Heyes J; Lutwyche P Adv Drug Deliv Rev; 2020; 154-155():37-63. PubMed ID: 32526452 [TBL] [Abstract][Full Text] [Related]
6. Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus. Sato Y; Matsui H; Yamamoto N; Sato R; Munakata T; Kohara M; Harashima H J Control Release; 2017 Nov; 266():216-225. PubMed ID: 28986168 [TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles as nucleic acid delivery system: properties and molecular mechanisms. de Jesus MB; Zuhorn IS J Control Release; 2015 Mar; 201():1-13. PubMed ID: 25578828 [TBL] [Abstract][Full Text] [Related]
8. A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation. Paunovska K; Sago CD; Monaco CM; Hudson WH; Castro MG; Rudoltz TG; Kalathoor S; Vanover DA; Santangelo PJ; Ahmed R; Bryksin AV; Dahlman JE Nano Lett; 2018 Mar; 18(3):2148-2157. PubMed ID: 29489381 [TBL] [Abstract][Full Text] [Related]
9. A tale of nucleic acid-ionizable lipid nanoparticles: Design and manufacturing technology and advancement. De A; Ko YT Expert Opin Drug Deliv; 2023 Jan; 20(1):75-91. PubMed ID: 36445261 [TBL] [Abstract][Full Text] [Related]
10. Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid. Jia Y; Wang X; Li L; Li F; Zhang J; Liang XJ Adv Mater; 2024 Jan; 36(4):e2305300. PubMed ID: 37547955 [TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of lipid nanoparticle to lymphatic endothelial cells via anti-podoplanin antibody. Sakurai Y; Abe N; Yoshikawa K; Oyama R; Ogasawara S; Murata T; Nakai Y; Tange K; Tanaka H; Akita H J Control Release; 2022 Sep; 349():379-387. PubMed ID: 35787913 [TBL] [Abstract][Full Text] [Related]
12. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes. Hashiba K; Sato Y; Harashima H J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839 [TBL] [Abstract][Full Text] [Related]
13. Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver. Kim M; Jeong M; Hur S; Cho Y; Park J; Jung H; Seo Y; Woo HA; Nam KT; Lee K; Lee H Sci Adv; 2021 Feb; 7(9):. PubMed ID: 33637537 [TBL] [Abstract][Full Text] [Related]
14. Lipid nanoparticles as vehicles for macromolecules: nucleic acids and peptides. del Pozo-Rodríguez A; Delgado D; Solinís MA; Gascón AR Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):214-26. PubMed ID: 21834776 [TBL] [Abstract][Full Text] [Related]
15. Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells. Liu GW; Guzman EB; Menon N; Langer RS Pharm Res; 2023 Jan; 40(1):3-25. PubMed ID: 36735106 [TBL] [Abstract][Full Text] [Related]
16. Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform. Bailey-Hytholt CM; Ghosh P; Dugas J; Zarraga IE; Bandekar A J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720139 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics. Mukai H; Ogawa K; Kato N; Kawakami S Drug Metab Pharmacokinet; 2022 Jun; 44():100450. PubMed ID: 35381574 [TBL] [Abstract][Full Text] [Related]
18. High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing. Sago CD; Lokugamage MP; Paunovska K; Vanover DA; Monaco CM; Shah NN; Gamboa Castro M; Anderson SE; Rudoltz TG; Lando GN; Munnilal Tiwari P; Kirschman JL; Willett N; Jang YC; Santangelo PJ; Bryksin AV; Dahlman JE Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9944-E9952. PubMed ID: 30275336 [TBL] [Abstract][Full Text] [Related]
19. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. Cheng X; Lee RJ Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977 [TBL] [Abstract][Full Text] [Related]